Cargando…

A new implant device to prevent edema-associated underdosage in high-dose-rate interstitial brachytherapy of mobile tongue cancer

PURPOSE: Tongue edema is a potential cause of treatment target underdosage in high-dose-rate interstitial brachytherapy (HDR-ISBT) of mobile tongue cancer. To prevent such edema-associated alteration of dosimetry, we developed a special silicon device. In this report we communicate our initial exper...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshida, Ken, Kotsuma, Tadayuki, Akiyama, Hironori, Yamazaki, Hideya, Takenaka, Tadashi, Masui, Koji, Tsujimoto, Yutaka, Murakami, Naoya, Uesugi, Yasuo, Shimbo, Taiju, Yoshikawa, Nobuhiko, Yoshioka, Hiroto, Nakata, Mio, Arika, Takumi, Takaoka, Yuji, Tanaka, Eiichi, Tselis, Nikolaos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964338/ https://www.ncbi.nlm.nih.gov/pubmed/31969916 http://dx.doi.org/10.5114/jcb.2019.91225

Ejemplares similares

Edema worsens target coverage in high-dose-rate interstitial brachytherapy of mobile tongue cancer: a report of two cases
por: Yoshida, Ken, et al.
Publicado: (2017)

Three-dimensional image-based high-dose-rate interstitial brachytherapy for mobile tongue cancer
por: Yoshida, Ken, et al.
Publicado: (2014)

High-dose-rate interstitial brachytherapy for mobile tongue cancer: preliminary results of a dose reduction trial
por: Akiyama, Hironori, et al.
Publicado: (2014)

Role of vaginal pallor reaction in predicting late vaginal stenosis after high-dose-rate brachytherapy in treatment-naive patients with cervical cancer
por: Yoshida, Ken, et al.
Publicado: (2015)

Effect of a lead block on alveolar bone protection in image-guided high-dose-rate interstitial brachytherapy for tongue cancer: using model-based dose calculation algorithms to correct for inhomogeneity
por: Akiyama, Hironori, et al.
Publicado: (2022)

High-dose-rate interstitial brachytherapy with hypoxic radiosensitizer KORTUC II for unresectable pelvic sidewall recurrence of uterine cervical cancer: a case report
por: Nakata, Mio, et al.
Publicado: (2020)

Initial tumor volume as an important predictor for indication of intra-cavitary brachytherapy, intra-cavitary/interstitial brachytherapy, and multi-catheter sole interstitial brachytherapy in cervical cancer patients treated with chemoradiotherapy
por: Takenaka, Tadashi, et al.
Publicado: (2023)

HDR-brachytherapy for accelerated partial breast irradiation: Long-term experience from a Japanese institution
por: Yoshida, Ken, et al.
Publicado: (2023)

Age is not a limiting factor for brachytherapy for carcinoma of the node negative oral tongue in patients aged eighty or older
por: Yamazaki, Hideya, et al.
Publicado: (2010)

KORTUC, a novel hydrogen peroxide‑based radiosensitizer for the enhancement of brachytherapy in patients with unresectable recurrent uterine cervical cancer
por: Shimbo, Taiju, et al.
Publicado: (2023)

New enzyme-targeting radiosensitizer (KORTUC II) treatment for locally advanced or recurrent breast cancer
por: Shimbo, Taiju, et al.
Publicado: (2021)

High-Dose-Rate Brachytherapy Monotherapy versus Image-Guided Intensity-Modulated Radiotherapy with Helical Tomotherapy for Patients with Localized Prostate Cancer
por: Yamazaki, Hideya, et al.
Publicado: (2018)

Radiotherapy for Elderly Patients Aged ≥75 Years with Clinically Localized Prostate Cancer—Is There a Role of Brachytherapy?
por: Yamazaki, Hideya, et al.
Publicado: (2018)

An extended dose–volume model in high dose‐rate brachytherapy – Using mean‐tail‐dose to reduce tumor underdosage
por: Morén, Björn, et al.
Publicado: (2019)

An easy and novel method for safer brachytherapy: real-time fluoroscopic verification of high-dose-rate (192)Ir source position using a flat-panel detector
por: Nose, Takayuki, et al.
Publicado: (2019)

Dose reduction trial from 60 Gy in 10 fractions to 54 Gy in 9 fractions schedule in high-dose-rate interstitial brachytherapy for early oral tongue cancer
por: Akiyama, Hironori, et al.
Publicado: (2012)

Predictive value of skin invasion in recurrent head and neck cancer patients treated by hypofractionated stereotactic re-irradiation using a cyberknife
por: Yamazaki, Hideya, et al.
Publicado: (2015)

Reirradiation using robotic image-guided stereotactic radiotherapy of recurrent head and neck cancer
por: Yamazaki, Hideya, et al.
Publicado: (2016)

Effect of intratumoral abscess/necrosis on the outcome for head and neck cancer patients treated by hypofractionated stereotactic re-irradiation using CyberKnife®
por: Yamazaki, Hideya, et al.
Publicado: (2017)

Low Health System Performance, Indigenous Status and Antivenom Underdosage Correlate with Spider Envenoming Severity in the Remote Brazilian Amazon
por: Sampaio, Vanderson Souza, et al.
Publicado: (2016)

Single-fraction image-guided high-dose-rate brachytherapy for head and neck cancer: three cases of palliative brachytherapy
por: Ota, Yoshiaki, et al.
Publicado: (2020)

Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2020)

Effect of Androgen Deprivation Therapy on Other-Cause of Mortality in Elderly Patients with Clinically Localized Prostate Cancer Treated with Modern Radiotherapy: Is There a Negative Impact?
por: Yamazaki, Hideya, et al.
Publicado: (2019)

A successful approach for angiosarcoma of the scalp using helical tomotherapy and customized surface mold brachytherapy: A case report
por: Suzuki, Gen, et al.
Publicado: (2021)

Is perioperative brachytherapy effective in carcinoma of the tongue?
por: Santos, Miguel, et al.
Publicado: (2022)

Abscopal effect of high-dose-rate brachytherapy on pelvic bone metastases from renal cell carcinoma: a case report
por: Suzuki, Gen, et al.
Publicado: (2019)

Small bowel perforation caused by applicator implantation in high-dose-rate interstitial brachytherapy for recurrent pelvic tumor: a case report
por: Masui, Koji, et al.
Publicado: (2020)

Radioimmunotherapy: future prospects from the perspective of brachytherapy
por: Fleischmann, Maximilian, et al.
Publicado: (2021)

High dose rate brachytherapy for oral cancer
por: YamazakI, Hideya, et al.
Publicado: (2013)

Results of sole postoperative interstitial, high-dose-rate brachytherapy of T1–2 tongue tumours
por: Takácsi-Nagy, Zoltán, et al.
Publicado: (2022)

The emerging role of high-dose-rate (HDR) brachytherapy as monotherapy for prostate cancer
por: Yoshioka, Yasuo, et al.
Publicado: (2013)

Comparison of dose–volume analysis between standard Manchester plan and magnetic resonance image-based plan of intracavitary brachytherapy for uterine cervical cancer
por: Takenaka, Tadashi, et al.
Publicado: (2012)

Inverse planning optimization with lead block effectively suppresses dose to the mandible in high-dose-rate brachytherapy for tongue cancer
por: Akino, Yuichi, et al.
Publicado: (2023)

Long-term outcome of high-dose-rate brachytherapy and perioperative brachytherapy in early mobile tongue cancer
por: Potharaju, Mahadev, et al.
Publicado: (2018)

High dose rate interstitial brachytherapy for early stage lip cancer using customized dental spacer
por: Masui, Koji, et al.
Publicado: (2020)

Brachytherapy of tongue carcinoma in a patient with difficult airway: anesthetic considerations
por: Ghaffar, Zainab Abdul, et al.
Publicado: (2018)

The role of brachytherapy for margin control in oral tongue squamous cell carcinoma
por: Ianovski, Ilia, et al.
Publicado: (2020)

Dose coverage comparison between “interstitial catheter-only” and “hybrid intracavitary-interstitial brachytherapy” for early stage squamous cell carcinoma of the buccal mucosa
por: Murakami, Naoya, et al.
Publicado: (2018)

Hyaluronic gel injection into the vesicovaginal septum for high-dose-rate brachytherapy of uterine cervical cancer: an effective approach for bladder dose reduction
por: Murakami, Naoya, et al.
Publicado: (2019)

Challenge and Outcome for the Prostate Squamous Cell Carcinoma Which Developed 8 Years after Low-Dose-Rate Brachytherapy Approached by a Combined Multimodal Treatment with High-Dose-Rate Interstitial Brachytherapy, External Beam Radiation Therapy, and Chemotherapy
por: Matsugasumi, Toru, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9rneprohvajoavkrsanbmrngk1